Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial-Reference-Cited by-同舟云学术

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial

Published:2019-01-16 Issue:5 Volume:181 Page:954-966
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Reich K.¹²,Sullivan J.³,Arenberger P.⁴,Mrowietz U.⁵,Jazayeri S.⁶,Augustin M.⁷^ORCID,Parneix A.⁸,Regnault P.⁹,You R.¹⁰,Milutinovic M.⁹

Affiliation:

1. Dermatologikum Berlin Friedrichstraße 89 10117 Berlin Germany

2. SCIderm Research Institute Hamburg Germany

3. Kingsway Dermatology & Aesthetics Miranda NSW Australia

4. Department of Dermatology Charles University Third Faculty of Medicine Prague Czech Republic

5. Psoriasis Center at the Department of Dermatology University Medical Center Schleswig‐Holstein Campus Kiel Germany

6. Alliance Dermatology and Mohs Center Phoenix AZ U.S.A.

7. Universität Hamburg Hamburg Germany

8. Novartis Pharmaceuticals Corporation East Hanover NJ U.S.A.

9. Novartis Pharma AG Basel Switzerland

10. Beijing Novartis Pharma Co. Ltd Beijing China

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17351

Reference29 articles.

1. Cytokine-Based Therapy in Psoriasis

2. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy

3. The Burden of Nail Psoriasis: An Introduction

4. Biological therapy and nail psoriasis

5. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is New in Nail Psoriasis?;Skin Appendage Disorders;2024-07-22

2. Treatment of Nail Psoriasis;Dermatologic Clinics;2024-07

3. Therapy of netakimab in nail psoriasis;Meditsinskiy sovet = Medical Council;2024-03-08

4. Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials;Frontiers in Medicine;2024-03-06

5. Acquired Disorders of the Nails and Nail Unit;Rook's Textbook of Dermatology;2024-02-20